Confluent Medical Technologies, formed last year when Nitinol Devices & Components acquired Interface Catheter Solutions, last week said it closed another buyout for an unspecified amount.
Fremont, Calif.-based Confluent said it acquired ETE Medical and subsidiaries Biomedical Structures, which makes biomedical textile implants, and Modified Polymer Components, which makes precision polymer components.
“The acquisition of Biomedical Structures and Modified Polymer Components is another step in our strategy of expanding our portfolio of world-class medical technologies,” Confluent president & CEO Dean Schauer said in prepared remarks. “The combination of Confluent Medical with Biomedical Structures and Modified Polymer Components allows us to provide our customers with a consolidated organization for the full-scale design, testing, and manufacturing of their life-saving devices. We are thrilled to be able to provide our customers with an expanded suite of industry-leading technologies as well as efficient high-quality, cost-competitive, best-in-class manufacturing.”
All of the companies were partially owned by Ampersand Capital Partners; Confluent said August 10 that the venture capital shop “will be a significant investor.”